← Eichor
Study identifier: NCT07026110 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer

Condition: Lung Cancer · Lung Diseases · Lung Neoplasms  ·  Sponsor: RenJi Hospital

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to explore the efficacy of Trop2, EpCAM-specific PET/CT imaging for noninvasive visualization of Trop2 or EpCAM expression levels in non-small cell lung cancer; and to explore the differences between novel target-specific PET/CT examinations and conventional 18F-FDG PET/CT in the diagnosis and differential diagnosis of solid lung nodules.

This description comes directly from the study's public registry record.

Talk to the study team

Weijun Wei  ·  15000083153  ·  wwei@shsmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07026110